resTORbio, Inc. Loss Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of resTORbio, Inc. (“resTORbio” or the “Company”) (NASDAQ: TORC) with Adicet Bio, Inc. (“Adicet”). Under the terms of the merger, Adicet would merge with a wholly-owned subsidiary of resTORbio in an all-stock transaction, and the equityholders of Adicet would become the majority owners (75%) of resTORbio’s outstanding common stock upon the close of the merger.

The resTORbio merger investigation concerns whether the Board of resTORbio breached their fiduciary duties to stockholders by agreeing to enter into this transaction and whether the merger undervalues resTORbio relative to Adicet, thereby harming resTORbio shareholders.